 |
Nuvalent
Last updated: September 02, 2025
Founder Matthew Shair
USA | Funding: $1.3B (+)
Website: https://www.nuvalent.com/
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Website: https://www.nuvalent.com/
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
